A
$ Value
$0
Shares
22,845
Price
$0
Filed
Mar 17
Insider
Name
Sawicki Mark W
Title
Chief Scientific Officer
CIK
0001848218
Roles
Officer
Transaction Details
Transaction Date
2026-03-14
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
106,932
Footnotes
Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027. | Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. | 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.
Filing Info
Sawicki Mark W's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-23 | CYRX | ▼ | $11K |
| 2026-03-16 | CYRX | ▼ | $26K |
| 2026-03-14 | CYRX | A | $0 |
| 2026-03-14 | CYRX | A | $0 |
Other Insiders at CYRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
STEFANOVICH ROBERT
Chief Financial Officer
|
— | $331K | 2026-03-23 |
|
SHELTON JERRELL
President, CEO
|
— | $87K | 2026-04-21 |
|
ZECCHINI EDWARD J
See Remarks
|
— | $16K | 2026-03-16 |
|
Sawicki Mark W
Chief Scientific Officer
|
— | $37K | 2026-03-23 |